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GIANT CELL (TEMPORAL) ARTERITIS
W I L L I A M C . NOSHAY, M.D.*

AND RICHARD L . ROTH,

M.D.**

GIANT CELL ARTERITIS is a wide-spread inflammatory disease of the arteries, occurring
in elderly patients. The most striking signs and symptoms of this disorder in its
classic form result from the involvement of cranial arteries. Since it was originally
defined as a clinical entity by Horton* in 1932, however, the concept of this disease
has changed considerably.
Giant cell arteritis was initially regarded as a benign, self-limited disease affecting
primarily the temporal arteries. As early as 1941, however, Gilmour' clearly demonstrated the diffuse nature of the arteritis and introduced the less restrictive title of
giant cell arteritis. In 1951, Cardell' reviewed the 27 fatal cases which had been
reported and added another of his own, emphasizing the diffuse and potentially fatal
nature of the disease. More recently Paulley and Hughes'' reviewed their 75 cases
and observed that "giant cell arteritis once believed to run a benign course, kills or
maims a number of those afflicted, and when in remission, it may only sleep".
They stressed the protean and potentially serious nature of the disease, and emphasized
the possibility of late, transient, or lack of involvement of the temporal arteries. A
brief review of four cases will illustrate some of the important features of the
disease, and its treatment.
CASE I (K. F.) — Age 72. admitted 9/19/50, discharged 10/24/50. A 72 year old woman
was admitted to the hospital because of blindness of the left eye of three days duration.
For four days prior to the onset of the blindness, there were intermittent episodes of loss
of vision in the same eye. She had had persistent head pains for one month.
On examination the temporal vessels were prominent, tortuous and tender. There
was blindness of the left eye and the optic disc was pale. Transient blindness occured in
the right eye on two occasions after admission, without subsequent persistent loss of vision.
With no specific therapy the head pain subsided over a period of four months. The
left eye remained blind and the optic disc was atrophic. The temporal arteries persisted
as hard cords.
Comment:
This patient represents the commonly recognized "classic" picture of temporal arteritis
in its self-limited form, complicated by optic atrophy with blindness.
CASE 2 (B. W.) — 82, admitted 10/23/56, discharged 11/3/56. This 82 year old man
was admitted to the hospital one day following the abrupt onset of blurred vision in the
right eye. For three weeks prior to his admission, there was persistent pain over the
left side of the head.
On examination the temporal vessels were prominent, irregular and tender, especially
on the left. The right optic disc was blurred, and on the following day, when the vision
was reduced to counting fingers, the disc was indistinct and slightly elevated with some
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small hemorrhages superiorly. The visual fields showed a large superior altitudinal central
scotoma on the right. On the following day he was started on Prednisone, 60 mg. daily.
The left temporal artery was resected and showed typical changes of giant cell arteritis
(Figure 1).
The patient's headache was promptly relieved following the resection and institution
of steroid therapy, and his vision gradually improved to 20/30 with a residual small
superior altitudinal scotoma on the right.
Comment:
This patient's course was quite similar to that of the preceding patient, but illustrates
the possible restoration of vision with prompt steroid therapy.
CASE 3 ( M . B.) — 77, admitted, 8/1/58, discharged 9/11/58. On admission to die hospital,
this 77 year old woman complained of generalized weakness, aches and pains in the neck,
shoulders and extremities, with diffuse aching soreness and tenderness of the head. The
illness began four months prior to admission, with shooting pains in the head, face and
ears. She became markedly anorexic, lost 15 lbs., and felt weak and fadgued. There
were periods of confusion of variable degree.
One month prior to admission she began having drenching sweats in association with
the appearance of tender, elevated, red nodules over the forehead.
On examination, the patient appeared chronically i l l . She was dull and somewhat
depressed. There were dime-sized erythematous nodules along the course of the temporal
arteries, particularly on the right. The right temporal artery was firm and acutely tender,
with decreased pulsation. The optic discs and fields were normal. The remainder of the
neurologic examination was not remarkable.
The sedimentation rate was 40 mm/hr. and the hemoglobin 10.5 gms. There was a
daily afternoon temperature rise, to about 101.6. The temporal artery was resected and
showed typical changes of temporal arteritis.
She was given two injections of Hydrocortisone 100 mg. four hours apart in the
evening, and on the following day felt markedly improved, with relief of the aching soreness
in the head. The erythematous nodules over the forehead and the fever subsided in approximately 48 hours. Hydrocortisone 160 mg. was condnued daily for one month.
Following discharge f r o m the hospital, the dosage of Hydrocortisone was gradually
reduced and then discondnued at the end of three months. One month later, the patient
was re-admitted to the hospital, complaining of excessive fatigue, with pain and sdffness
in the back and thighs.
The temporal arteries felt irregular and hardened, but were not tender or inflamed.
She again showed a mild daily temperature rise to 100.
The blood hemoglobin was 9.7 gms. Serum electrophoresis showed a total protein of
6.1 (N 6.5-8.3) with albumin 2.35 (N 4.1-5.6), A, globulin 0.46 (N 0.17-0.37), A , globulin
0.87 (N 0.34-0.76), B globulin 0.87 (N 0.52-1.01), gamma globulin 1.55 (N 0.61-1.34).
On resumption of steroid therapy (Prednisone 5 mg. t.i.d.) the symptoms again subsided.
Five months later, steroid therapy was stopped a second time, and in two weeks she
again had a recurrence of headaches, soreness in the right temporal region and leg pains,
associated with vomiting for two days. During the course of this acute recurrence she
noted impairment of vision to the right and some weakness of the right side of the face.
There was no apparent facial weakness when she was seen several days after the onset
of this difficulty in the Clinic, but it was felt that she had a homonymous relative decrease
in the peripheral right field. Her symptoms again subsided on resumption of Prednisone
10 mg. daily. There was no further recurrence of symptoms when the Prednisone was
gradually discontinued again at the end of six months.
Comment:
This patient's illness was marked by prominent systemic complaints with periods of
confusion for several months prior to the appearance of obvious temporal artery involvernent. There was recurrence of symptoms on interruption of steroid therapy, three and
eight months after it was initiated. The second recurrence was associated with transient
left cerebral symptoms, possibly on the basis of cerebral ischemia.
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CASE 4 (B. E.) — Admitted 11/12/57, discharged 11/27/57. Eight weeks prior to admission,
this 61 year old woman began having left frontal throbbing headaches with a "flu-like"
illness. Abrupt loss of vision occurred in the left eye three weeks before admission. During
this illness she was anorexic and had a weight loss of 10 lbs.
Two weeks before the onset of symptoms, peniciUin had been applied locally after a
tooth extracdon and the following day, swelling of the left face and lips appeared. This
cleared completely in several days with antihistamine therapy. There was no previous
history of penicillin sensitivity. On admission the patient complained of persistent left
frontal pain, and loss of vision in ths left eye.
Neurologic examination revealed an optic neuritis with marked loss of vision on the
left. There was some residual vision in the upper nasal quadrant with a large central
defect. No definite abnormality of the temporal arteries was noted by several examiners,
even though ths possibility of temporal arteritis was considered.
An EEG showed a left fronto-temporal delta focus. In view of this finding and the
absence of apparent temporal artery disease, an arteriogram was done and this was normal.
The blood hemoglobin
fluid protein was 25 mg%.
61.7), gamma globulin 28%
(N 7.4-13.4) and alpha, 9%

was 9.5 gm., the sedimentation rate 45 mm/hr. The spinal
The total serum protein was 6.5 with albumin 27% (N 44.2(N II.3-24.9), beta globulin 14% (N 9.7-16.9), alpha^ 23%
(N 3.7-7.3).

The padent was discharged from the hospital on Prednisone 40 mg. daily. When she
was seen again, one week later, she was free of head pain and felt well. The optic
disc changes were subsiding, but there was no improvement in vision. Prednisone therapy
was discontinued at the end of two months, but was promptly reinsdtuted by her local
physician because of the recurrence of head pain, and this was again promptly relieved.
The patient was seen three years later, in Ophthalmology Clinic and was reported
to have no significant change in her visual field or acuity. She had had no further
recurrence of the difficulty, but the total duration of therapy was not recorded.
Cornment:
This padent was of particular interest in view of the absence of apparent involvement
of the temporal arteries even after the appearance of opdc nerve complicadons presumably
due to ophthalmic arteritis. It is quite possible the temporal arteries may have shown
histologic changes; but even without this evidence, her history and response to therapy
would appear to leave little doubt regarding the diagnosis. The occurrence of sympt9rns
in this patient within two weeks following an allergic reaction suggested the possibility
that the giant cell arteritis may have represented in this case a delayed hypersensitivity
phenomenon.
CLINICAL

PICTURE

Giant cell arteritis is a disease of elderly patients which occurs most commonly
past the age o f 60. There are at least two cases in the literature however, in which
the disease is reported in young women, but the diagnosis is open to question in at
least one. Gilmour's^ patient was a 23 year old woman w i t h a clinical picture more
consistent w i t h the diagnosis of pulseless disease (Takayasu's disease, aortic arch
syndrome). The pathology of the temporal artery in Meyer's" 22 year old patient
was not typical and suggests the possibility that this may have represented some
other f o r m of arteritis.
Although the onset, course and involvement in giant cell arteritis are varied,
pain in the head, neck or face, associated w i t h tenderness i n the region of the
involved temporal occipital or facial arteries, is usually a prominent feature of the
illness, initially or at sometime during the course of the disease. Systemic symptoms
including fever, anorexia, weakness, weight loss and pains in the joints and muscles
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often appear in association with the head pain and in many cases may precede it
for a month or more.
The head pain is often described as "sharp or shooting" with more persistent
aching and soreness in the head or scalp. It may fluctuate markedly in character
and severity and in some cases may be insignificant or obscured by other, more
dramatic symptoms. Visible or palpable changes in the affected arteries, usually
appear in association with the pain. Diffuse redness and swelling or erythematous
nodules may be seen in the skin overlying the involved vessels. The artery is
usually tender, thickened, and often nodular and tortuous. In some patients however,
pain, scalp tenderness and other symptoms may occur without obvious changes in
the cranial arteries, and Fisher' commented recently on the importance of careful
palpation for compressibihty of the cranial vessels, with biopsy of suspected vessels
for possible confirmation of the presence of giant cell arteritis.

\

I

Blindness, the most common serious complication of the disease, occurs in over
50 per cent of the patients. Loss of vision usually occurs from within a few days
up to ten months after the onset of symptoms, but it may be an initial symptom.'"
In some patients transient episodes of blindness occur with or without subsequent loss
of vision (Case 1). Such episodes may be confused with similar disturbances which
occur in carotid artery occlusive disease. The blindness usually occurs abruptly in
one eye and may be followed by involvement of the other eye within days or weeks.'""
If blindness is not complete, altitudinal and sector defects are most common, but any
form of field loss may result with involvement of the retina, optic nerves or
chiasm.^''^'" The visual loss is most often associated with an ischemic optic neuropathy
(Case 2 ) , due to arteritis of ophthalmic artery and its branches. Retrobulbar neuritis
(Case 1) and central retinal artery occlusion are less frequent causes.^" Before
steroid therapy, giant cell arteritis resulted in blindness in one or both eyes of
approximately 50 per cent of the patients. Blindness has been reported following
the institution of steroid therapy,""^ but Hollenhorst' reported that only one of their
patients lost vision after the onset of therapy. Improvement in vision may occur
following institution of therapy (Case 2 ) , and it is likely that subsequent involvement
of the second eye will be prevented if the period of therapy is sufficiently prolonged.
Ocular motor paralysis and diplopia without demonstrable palsy occur in about
15 per cent of the patients."' This complication usually appears prior to the onset
of visual loss and the paralysis is apt to fluctuate in character. Ptosis is the most
common finding, but any of the ocular muscles may be affected. Recovery often
occurs in days, but palsies may persist for months, and there may be permanent
residual impairment." As in the case of blindness, diplopia and ocular muscle palsy
may appear in the absence of gross evidence of arteritis, simulating in this case the
picture seen in diabetic opthalmoplegias.
Cerebral infarction is not a common complication but may occur during the
acute phase of the disease. Cranial arteritis occurs in patients in the age group
prone to develop arteriosclerotic and vascular lesions unrelated to the disease. It has
been demonstrated, however, on autopsy in some fatal cases, that giant cell arteritis
of the internal carotid and vertebral vessels may result in thrombosis and cerebral
458
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infarction.''^' Multiple areas of cerebral infarction may also be caused by embolization
from mural thrombi resulting from arteritic coronary artery occlusion.'^ Involvement
of the terminal cerebral vessels is not reported in these cases, but Crompton' recently
reported a fatal case with evidence of arteritis not only in the vertebrals, but also
in a branch of the posterior cerebral, as well as in small arteries in the roof of the
fourth ventricle and in the leptomeninges of the lower medulla. McCormick' reported
giant cell arteritis involving small meningeal and intracerebral vessels with severe
cerebral involvement in two patients, but the diagnosis was questionable in the patient
presenting the most striking small vessel changes.

I

Mental changes, manifested by confusion, dementia and depression, are relatively
common" during the course of the illness, and it is likely that these changes result
from ischemia or thrombembolic cerebral disease.
In his review of 75 cases of giant cell arteritis, Paulley," who prefers the use
of the term "arteritis of the aged", makes a vigorous plea for the recognition of the
atypical forms in which the classical symptoms may be lacking or overshadowed by
other major problems. In addition to the clinical pictures already described, he adds
as modes of presentation cardiac ischemia, anarthritic rheumatism, pain in the ear
with vertigo and deafness, vomiting and cachexia, episodes masquerading as meningeal
irritations, pyrexia of unknown origin, the aortic arch syndrome and dissecting
aneurysms of the aorta in the aged. In his report, he presents cases illustrating these
unusual atypical modes of presentation.

Figure la
Cross Section of temporal artery (Case 2) showing eccentric intimal proliferation and cellular
infiltration predominantly at the junction of the thickened intima and media.
(H & E stain 17 x)
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DIAGNOSIS
Biopsy of accessible involved cranial vessels usually reveals a characteristic picture
which is diagnostic of this disease, in combination with the varied clinical symptoms
described in an elderly patient.

t-

Figure l b
Segment of the wall of the artery in Fig. la showing cellular infiltration of mononuclear cells with
multinucleated giant cells in area of infiltration.
(H & E stain 170 x)
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The typical features seen in affected vessels include marked intimal proliferation
with obliteration of the lumen, degeneration of the internal elastic layer with giant
cells concentrated in this area, degenerative changes in the media, and cellular infiltration predominantly in the media but extending into the intima and adventitia (fig. 1).
In some patients the biopsy may be inconclusive or there may be no apparent
involvement of accessible vessels. In these cases a trial of steroid therapy should
be given for diagnostic as well as therapeutic purposes. This is preferable to delay
of treatment until the appearance of obvious vascular changes which may not occur
until serious complications have intervened."
Other laboratory studies, though not diagnostic, provide supportive evidence. The
erythrocyte sedimentation rate is usually grossly elevated, anemia with leukocytosis
is quite common, and protein electrophoresis is often abnormal with a decrease in
albumin and an increase in alpha or beta globulin fractions''"'" (Cases 3 and 4 ) .
The spinal fluid, although usually normal, may show an elevated protein.
TREA

TMENT

The response to steroid therapy in giant cell arteritis is usually prompt and often
dramatic, particularly in regard to the systemic symptoms and head pain. When
therapy is initiated prior to the onset of visual symptoms, the incidence of blindness,
as has been noted, may be insignificant, and the recovery of vision may occur in the
case of partial visual defects (Case 2). It is likely too, that fatalities which have
resulted largely from cerebral and coronary artery occlusion'" will be less common
in adequately treated patients. Hollenhurst' recommended a starting dose of 300 mg.
of cortisone, or its equivalent, followed by 150 to 200 mg. daily for four to six
weeks, with a maintenance dose of 50 to 75 mg. daily for three to four months.
Paulley" observed that Prednisone 10 mg., given twice daily was usually effective
in controlling the disease, while in some instances the dosage had to be increased
to 30 mg. three times a day, in the acute stage of the disorder. The maintenance
dose is variable but should be adequate to control remediable symptoms completely.
More prolonged maintenance therapy for from six to twelve months as suggested
by Paulley is advisable, as illustrated by the recurrences experienced by one of our
patients (Case 3) when therapy was discontinued at the end of three and again at
eight months. When therapy is discontinued prior to the subsidence of the disease
process, the symptoms seem to recur within a month and necessitate immediate
resumption of treatment. The use of anticoagulants in conjunction with steroid therapy
has been suggested,' but the satisfactory response obtained with steroids alone suggests
that combined therapy is not essential.
SUMMARY

Four cases of giant cell (temporal) arteritis of the aged illustrating some
important features of the disease and its treatment are presented with a review of the
literature emphasizing the less well recognized aspects of the disorder and the possible
absence of typical temporal arteritis. The use of steroids in suspected cases is
suggested, and the importance of early and prolonged therapy is stressed.
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